Abstract
Abstract BACKGROUND: According to the latest European guidelines on the management of non-valvular atrial fibrillation (NVAF), all patients aged ≥65 years should be treated with oral anticoagulation (if not contraindicated). Therefore, stroke risk factors should be investigated exclusively in NVAF patients aged
Original language | English |
---|---|
Journal | Chest |
DOIs | |
Publication status | Published - 16 Jun 2011 |